Bookbuilding IPO | ₹30 Cr | Listed at NSE SME | Wed, May 14, 2025 - Fri, May 16, 2025
| Category | QIB | NII | Retail | Total | ||
|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | ||||
| Allocation (No. of shares) | 1,41,600 | 2,11,200 | 3,52,800 | 12,22,800 | 12,22,800 | 27,98,400 |
| Allotment price (Rs.) | 101 | 101 | 101 | 101 | 101 | 101 |
| No.of applications | 4 | 2 | 6 | 899 | 10,801 | 11,706 |
| No.of shares applied | 1,47,600 | 2,11,200 | 3,58,800 | 51,62,400 | 1,25,78,400 | 1,80,99,600 |
| Amount collected (Rs.cr.) | 1.49 | 2.13 | 3.62 | 52.14 | 127.04 | 182.81 |
| No.of times subscribed | 1.04 | 1.00 | 1.02 | 4.22 | 10.29 | 6.47 |
| No.of shares allotted | 1,41,600 | 2,11,200 | 3,52,800 | 12,22,800 | 12,22,800 | 27,98,400 |
| Amount (Rs.cr.) | 1.43 | 2.13 | 3.56 | 12.35 | 12.35 | 28.26 |
| No.of allottees | 4 | 2 | 6 | 862 | 10,482 | 11,350 |
Accretion Pharmaceuticals IPO is a public issue of 0.28 Cr equity shares. The issue offers 0.12 Cr shares to retail investors, 0.04 Cr shares to qualified institutional buyers, and 0.12 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 1,47,600 | 1.49 | 5.01% |
| QIB | 3,52,800 | 3.56 | 11.98% |
| Anchor | 2,11,200 | 2.13 | 7.17% |
| QIB (Ex Anchor) | 1,41,600 | 1.43 | 4.81% |
| NII* | 12,22,800 | 12.35 | 41.51% |
| Retail | 12,22,800 | 12.35 | 41.51% |
| Total | 29,46,000 | 29.75 | 100% |
A total of 2,11,200 shares at a price of Rs 101 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | May 13, 2025 |
| Anchor investor price | ₹101.00 |
| Anchor investors as % of QIBs | 59.86% |
| No. of shares locked-in for 30 days | 1,05,600 |
| No. of shares locked-in for 90 days | 1,05,600 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
| S.No. | Anchor Investor | Group Entity | No. of Shares Allotted | Amount (Rs.cr.) | % Allotment within Anchor Investor Portion | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | PINE OAK GLOBAL FUND | PINE OAK | 1,05,600 | 1.07 | 50.00 | 3.58 |
| 2 | VIKASA CAPITAL INC. | VIKASA | 1,05,600 | 1.07 | 50.00 | 3.58 |
| 2,11,200 | 2.13 | 100 | 7.17 |
The Accretion Pharmaceuticals IPO is subscribed 7.67 times by May 16, 2025 18:19.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 12.14 |
| Non Institutional | 4.28 |
| Retail Individual | 10.54 |
| Total Subscription | 7.67 |
An investor can apply in Accretion Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Accretion Pharmaceuticals IPO shares are offered online only.
The Accretion Pharmaceuticals IPO is subscribed 7.67 times by May 16, 2025 18:19.
The Accretion Pharmaceuticals IPO allotment status is expected on or around Monday, May 19, 2025. Visit Accretion Pharmaceuticals IPO allotment status to check.
The Accretion Pharmaceuticals IPO listing date is May 21, 2025. The equity share of Accretion Pharmaceuticals IPO will list on NSE SME.
Visit Accretion Pharmaceuticals IPO subscription status page for real-time bidding information about Accretion Pharmaceuticals IPO.
| IPO opens On | Wednesday, May 14, 2025 |
| IPO Closes On | Friday, May 16, 2025 |
| Finalisation of Basis of Allotment | Monday, May 19, 2025 |
| Initiation of Refunds | Tuesday, May 20, 2025 |
| Credit of Shares to Demat Account | Tuesday, May 20, 2025 |
| IPO Listing Date | Wednesday, May 21, 2025 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
